Osteoporosis International

, Volume 14, Issue 9, pp 722–727

Mortality and morbidity associated with osteoporosis drug treatment following hip fracture

  • Marilyn W. Cree
  • Angela G. Juby
  • Keumhee C. Carriere
Original Article

Abstract

This study examined post-fracture osteoporosis drug treatment in hip fracture patients and the association of treatment with mortality and morbidity. Pre- and post-fracture demographic/health information was collected on a cohort of hip fracture patients aged 65+ years. Post-fracture administrative data on prescription drug use and health care utilization was linked to the cohort data. Five classes of osteoporosis drugs were available during the study period: hormone replacement therapy (HRT), bisphosphonates (BSP), calcitonin, selective estrogen receptor modulators (SERMs) and vitamin D3 (Rocaltrol). Pre-fracture, 38 of 449 patients (8%) were on osteoporosis medications. Post-fracture, 81 of 356 patients (23%) were treated; 63 of these patients were untreated prior to fracture. Both treated and untreated patients had similar rates of subsequent hip fracture (6% and 4%, respectively) and Colles fracture (2%). Regardless of treatment status, patients were also equally likely to be hospitalized, both in the short-term (28% in treated, 27% in untreated) and in the long-term (43% versus 37%). However, mortality was significantly lower in the treated group. The lower mortality in the treated group, combined with the knowledge that antiresorptive drugs reduce fractures and increase bone density, merit undertaking a randomized trial to confirm our findings that antiresorptive therapy should be considered in all patients post-hip fracture.

Keywords

Elderly Hip fracture Morbidity Mortality Osteoporosis Treatment 

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2003

Authors and Affiliations

  • Marilyn W. Cree
    • 1
  • Angela G. Juby
    • 2
  • Keumhee C. Carriere
    • 1
    • 3
  1. 1.Department of Mathematical and Statistical SciencesUniversity of AlbertaEdmontonCanada
  2. 2.Division of Geriatrics, Department of MedicineUniversity of AlbertaEdmontonCanada
  3. 3.632 Central Academic Building, Department of Mathematical and Statistical SciencesUniversity of AlbertaEdmontonCanada

Personalised recommendations